WATERS CORP /DE/ WAT
NYSE · XNYS · stock · Laboratory Analytical Instruments · website · IPO 1995-11-17
WATERS CORP /DE/ financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $3.2B | $3.0B | $3.0B | $3.0B | $2.8B |
| R&D expense | $195.7M | $183.0M | $174.9M | $176.2M | $168.4M |
| SG&A expense | $830.4M | $690.1M | $736.0M | $658.0M | $627.0M |
| Operating income | $802.6M | $826.4M | $817.7M | $873.4M | $821.7M |
| Interest expense | $69.5M | $89.7M | $98.9M | $48.8M | $44.9M |
| Income tax | $112.2M | $117.0M | $94.0M | $130.1M | $113.3M |
| Net income | $642.6M | $637.8M | $642.2M | $707.8M | — |
| EPS (diluted) | $10.76 | $10.71 | $10.84 | $11.73 | $11.17 |
| Operating cash flow | $652.6M | $762.1M | $602.8M | $611.7M | $747.3M |
| Cash & equivalents | $588.0M | $325.4M | $395.1M | $480.5M | $501.2M |
| Inventory | $572.0M | $477.3M | $516.2M | $455.7M | $356.1M |
| Total assets | $5.1B | $4.6B | $4.6B | $3.3B | $3.1B |
| Total liabilities | $2.5B | $2.7B | $3.5B | $2.8B | $2.7B |
| Shareholders' equity | $2.6B | $1.8B | $1.2B | $504.5M | $367.6M |
Source: SEC EDGAR filings · CIK 0001000697 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.